共 50 条
- [42] Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (05): : 586 - 589
- [43] Physician-assessed effectiveness, patient-reported outcomes, and safety in adult and adolescent patients with atopic dermatitis treated with dupilumab: real-world insights 1 year into the GLOBOSTAD multinational prospective observational study BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I56 - I57